Roman Butler Fullerton & Co’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$675K Buy
+15,277
New +$657K 0.19% 132
2025
Q4
Sell
-14,156
Closed -$558K 267
2025
Q3
$558K Buy
+14,156
New +$569K 0.15% 146

Other funds holding EXEL

Roman Butler Fullerton & Co's EXEL Position: Q1 2026 in Review

Roman Butler Fullerton & Co opened a new position in Exelixis (EXEL) in Q1 2026: 15,277 shares worth $675K. The stake represents 0.19% of the portfolio and ranks #132 among its holdings. This is a return to the name: Roman Butler Fullerton & Co previously reported a position in EXEL as recently as Q3 2025.

Roman Butler Fullerton & Co first reported a position in EXEL in Q3 2025 and has held it in 2 quarters since. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Roman Butler Fullerton & Co held 15,277 shares of Exelixis worth $675K as of Q1 2026.
  • Exelixis was a new Roman Butler Fullerton & Co position in Q1 2026.
  • Exelixis made up 0.19% of Roman Butler Fullerton & Co's portfolio in Q1 2026, its #132 holding.
  • Roman Butler Fullerton & Co first reported a position in Exelixis in Q3 2025 and has held it in 2 quarters since.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Roman Butler Fullerton & Co's 13F filing for Q1 2026, filed 30 Apr 2026.